Paul Moore
About Paul Moore
Paul Moore Chief Scientific Officer
Paul Moore serves as the Chief Scientific Officer. With over 25 years of experience in biologics drug discovery and development, Moore has a well-established career in the biotech industry. His expertise encompasses scientific collaborations with leading pharmaceutical partners such as Pfizer, Servier, Gilead, Takeda, Janssen, Roche, and Zai Labs. His work has significantly contributed to the advancement of numerous clinical-stage compounds.
Paul Moore Education and Expertise
Paul Moore holds a PhD in molecular genetics from the University of Glasgow and a degree in Biotechnology from the University of Strathclyde. He further specialized through post-doctoral work at the Roche Institute of Molecular Biology in Nutley, New Jersey. His academic background and extensive research in molecular genetics and biotechnology underpin his contributions to the field of biologics drug discovery and development.
Paul Moore Background in Biologics Drug Discovery
Paul Moore launched his career at Human Genome Sciences (HGS), where he advanced through various roles culminating in the position of Director of Lead Product Development. His work involved managing genomic-based target discovery programs, contributing to the discovery, development, approval, and commercialization of Benlysta (belimumab) for the treatment of systemic lupus erythematosus. Moore's extensive experience in biologics is evident from his roles in different prominent biotech companies.
Paul Moore Career at MacroGenics and Celera
Before becoming Chief Scientific Officer, Paul Moore served as Vice President of Cell Biology and Immunology at MacroGenics. His role involved developing clinical stage compounds and fostering collaborations with pharmaceutical companies. As Director of Cell Biology at Celera, he led research endeavors to develop novel antibody-based therapeutics. His leadership and research have been crucial in pushing forward the frontiers of cell biology and immunology.
Paul Moore Publications and Patents
Paul Moore has co-authored over 75 peer-reviewed manuscripts and is named as a co-inventor on more than 50 issued US patents. His extensive body of work highlights his contributions to the scientific community and his role in advancing research in molecular genetics and biotechnology.